Selux Diagnostics is developing a Next Generation Phenotyping (NGP) platform that promises to transf
Employees: 51-200
Phone: +1 617-945-9383
Total raised: $112.6M
Founded date: 1983
Investors 2
| Date | Name | Website |
| - | Schooner C... | schoonerca... |
| - | RA Capital... | racap.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 01.04.2024 | - | $48M | - |
| 28.02.2022 | Series C | $50M | - |
| 08.06.2021 | - | $14.6M | - |
Mentions in press and media 15
| Date | Title | Description |
| 01.04.2024 | Selux Diagnostics Raises Additional $48M in Funding | Selux Diagnostics, Inc., a Boston, MA-based biotech startup whose mission is to combat superbug infections and fight antimicrobial resistance (AMR), raised an additional $48 in funding. The round was led by RA Capital Management with partic... |
| 20.01.2023 | Selux Receives FDA Clearance for its Rapid Antibiotic Susceptibility Test (AST) System | What You Should Know: |
| 12.07.2022 | Selux Diagnostics Receives $8.0 Million in Additional Funding to Redefine Speed in Microbiology Laboratory Testing | BOSTON, July 12, 2022 (GLOBE NEWSWIRE) -- Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antimicrobial resistance (AMR), today announced that it has been awarded an addit... |
| 01.03.2022 | Selux Diagnostics Raises Additional $50M in Series C Funding | Selux Diagnstics, a Boston, MA-based company developing precision diagnostics for infectious diseases, raised $50M in Series C funding. The round was led by RA Capital Management, with participation from Sands Capital, Schooner Capital and ... |
| 28.02.2022 | Selux Diagnostics Raises $50M for Next-Generation Phenotyping Platform | What You Should Know: – Selux Diagnostics, Inc., a personalized diagnostics company to combat superbug infections and fight antibiotic resistance raises $50M in Series C financing led by RA Capital Management, with participation from Sands ... |
| 28.02.2022 | Selux Diagnostics Scores $50M in Series C | BOSTON, MA, Selux Diagnostics, a diagnostics startup, has raised $50 million in Series C financing. >> Click here for more funding data on Selux Diagnostics >> To export Selux Diagnostics funding data to PDF and Excel, click... |
| 08.06.2021 | Selux Diagnostics Receives Additional $14.6 Million in BARDA Funding After Successfully Completing First Clinical Trial | |
| 27.04.2020 | Selux Diagnostics receives $9.6M for development of rapid antimicrobial testing | Selux Diagnostics, a Charlestown-based biotech startup, received $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services. The startup develops a di... |
| 24.10.2019 | New diagnostic tools are essential in the battle against antibiotic resistance | A century ago, a severe bacterial infection was often a death sentence. With the advent of penicillin and the antibiotics that followed, such infections became eminently manageable, even routine. Today, though, with the rise of antimicrobia... |
| 09.10.2019 | SeLux leverages government support to develop rapid antibiotic susceptibility test | Lufkin believes current susceptibility testing takes too long – three to five days. During that period, patients are often treated with broad-spectrum antibiotics to ensure all bases are covered. “The good news is, it’s going to save your l... |
Show more